Tuesday - September 22, 2026
GSK's Shingrix Prefilled Syringe Presentation Approved in Japan
September 11, 2026
LONDON, England, Sept. 11 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Sept. 10, 2026:

* * *

GSK's Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Japan

* Over one million people develop shingles in Japan each year/1,2

* New presentation offers convenient administration of GSK's shingles vaccine

-

GSK plc (LSE/NYSE: GSK) . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products